HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Asymptomatic Infections

Infections that do not exhibit symptoms.
Also Known As:
Asymptomatic Infection; Infection, Asymptomatic; Infection, Subclinical; Infections, Asymptomatic; Infections, Subclinical; Subclinical Infection; Subclinical Infections
Networked: 663 relevant articles (31 outcomes, 46 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infection
2. Visceral Leishmaniasis (Kala Azar)
3. Leprosy (Hansen's Disease)
4. Malaria
5. Necrosis

Experts

1. Zink, M Christine: 4 articles (10/2006 - 10/2002)
2. Melby, Peter C: 3 articles (11/2015 - 01/2002)
3. Doumbo, Ogobara K: 3 articles (04/2014 - 11/2005)
4. Kalantari, Mina: 3 articles (01/2014 - 12/2004)
5. Calleja-Macias, Itzel E: 3 articles (01/2014 - 12/2004)
6. Bernard, Hans-Ulrich: 3 articles (01/2014 - 12/2004)
7. Leitner, Gabriel: 3 articles (01/2014 - 11/2007)
8. Paiva, Adriana de Azevedo: 3 articles (05/2013 - 01/2011)
9. Marsh, Kevin: 3 articles (01/2011 - 11/2004)
10. Clements, Janice E: 3 articles (10/2006 - 10/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Asymptomatic Infections:
1. AntibodiesIBA
2. AntigensIBA
3. VaccinesIBA
4. Anti-Bacterial Agents (Antibiotics)IBA
5. DNA (Deoxyribonucleic Acid)IBA
6. C-Reactive ProteinIBA
7. Ganciclovir (Cytovene)FDA LinkGeneric
04/11/1991 - "Prophylactic ganciclovir is effective in preventing the development of CMV interstitial pneumonia in patients with asymptomatic infection."
04/15/1996 - "Three patients out of 17 did not develop cytomegalovirus infection and 14 did: 5 had symptomatic disease treated with ganciclovir and 9 developed asymptomatic infection and were not treated. "
01/01/2010 - "In symptomatic CMV infection 6 weeks treatment with ganciclovir is legitimate (decreases viruria and the risk of hearing impairment); while in asymptomatic infection with massive viral replication it can be considered as supposedly beneficial. "
07/01/2012 - "Studies evaluating treatment and long-term follow-up of infants with both symptomatic and asymptomatic infection are necessary, in order to definitely evaluate the short and long-term effectiveness and safety of both ganciclovir and valganciclovir and to identify risk factors associated to the development of long-term sequelae. "
01/01/2002 - "In recent years, three major strategies have been developed for the prevention of CMV disease in this population: reduction of risk of viral acquisition or reactivation by management of risk factors; prophylaxis of all 'at-risk' patients using prophylactic strategies for a defined period of time, initiated at or near the time of transplant; and pre-emptive treatment with ganciclovir of selected 'at-risk' patients, guided by either laboratory markers indicative of subclinical infection or the presence of specific risk factors. "
8. Interleukin-4 (Interleukin 4)IBA
9. O- (3,6- di- O- methylglucopyranosyl)- (1- 4)- O- (2,3- di- O- methylrhamnopyranosyl)- (1- 9)- oxynonanoyl- bovine serum albuminIBA
10. Itraconazole (Sporanox)FDA LinkGeneric

Therapies and Procedures

1. Breast Implants (Breast Implant)
2. Transplantation (Transplant Recipients)
3. Transplants (Transplant)
4. Blood Transfusion (Blood Transfusions)
5. Tocolysis